GLI1 and colonic neoplasm: Mazumdar et al. have tested two Hedgehog pathway inhibitors on colon cancer cell lines and concluded that inhibition works better at the level of GLI proteins rather than at the level of membrane component SMO, suggesting that GLI activation, possibly through non-canonical pathways, is the contributing factor in colon carcinogenesis [39].